1-5 of 5
Marta Hamilton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors

Amita Patnaik, Debra Wood, Anthony W. Tolcher, Marta Hamilton, Jeffrey I. Kreisberg, Lisa A. Hammond, Garry Schwartz, Muralidhar Beeram, Manuel Hidalgo, Monica M. Mita, Julie Wolf, Paul Nadler, Eric K. Rowinsky
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7406–7413.
https://doi.org/10.1158/1078-0432.CCR-06-1886
Published: 22 December 2006
View article titled, Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors
Open the PDF for Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors in another window
Journal Articles

Effects of Smoking on the Pharmacokinetics of Erlotinib

Marta Hamilton, Julie L. Wolf, Jason Rusk, Shannon E. Beard, Gary M. Clark, Karsten Witt, Pablo J. Cagnoni
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2166–2171.
https://doi.org/10.1158/1078-0432.CCR-05-2235
Published: 11 April 2006
View article titled, Effects of Smoking on the Pharmacokinetics of Erlotinib
Open the PDF for Effects of Smoking on the Pharmacokinetics of Erlotinib in another window
Journal Articles

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers

W. Jeffrey Petty, Konstantin H. Dragnev, Vincent A. Memoli, Yan Ma, Neil B. Desai, Adrian Biddle, Thomas H. Davis, William C. Nugent, Natalie Memoli, Marta Hamilton, Kenneth K. Iwata, James R. Rigas, Ethan Dmitrovsky
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (22): 7547–7554.
https://doi.org/10.1158/1078-0432.CCR-04-1169
Published: 29 November 2004
View article titled, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers
Open the PDF for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers in another window
Journal Articles

Structural Identification and Biological Activity of 7-Methyl-10,11-Ethylenedioxy-20( S )-Camptothecin, a Photodegradant of Lurtotecan

Walter J. Loos, Jaap Verweij, Diederik F. S. Kehrer, Peter de Bruijn, Franciscus M. H. de Groot, Marta Hamilton, Kees Nooter, Gerrit Stoter, Alex Sparreboom
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 856–862.
Published: 01 March 2002
View article titled, Structural Identification and Biological Activity of 7-Methyl-10,11-Ethylenedioxy-20( <em>S</em> )-Camptothecin, a Photodegradant of Lurtotecan
Open the PDF for Structural Identification and Biological Activity of 7-Methyl-10,11-Ethylenedioxy-20( <em>S</em> )-Camptothecin, a Photodegradant of Lurtotecan in another window
Journal Articles

Antitumor Efficacy, Pharmacokinetics, and Biodistribution of NX 211: A Low-Clearance Liposomal Formulation of Lurtotecan

David L. Emerson, Ray Bendele, Eric Brown, SuMing Chiang, John P. Desjardins, Larry C. Dihel, Stan C. Gill, Marta Hamilton, Jeremy D. LeRay, Lotus Moon-McDermott, Karen Moynihan, Frank C. Richardson, Blake Tomkinson, Michael J. Luzzio, David Baccanari
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (7): 2903–2912.
Published: 01 July 2000
View article titled, Antitumor Efficacy, Pharmacokinetics, and Biodistribution of NX 211: A Low-Clearance Liposomal Formulation of Lurtotecan
Open the PDF for Antitumor Efficacy, Pharmacokinetics, and Biodistribution of NX 211: A Low-Clearance Liposomal Formulation of Lurtotecan in another window